Home › NDC Lookup › RxCUI directory › RxCUI 1486691

Sapropterin dihydrochloride 100 MG Oral Tablet [Kuvan] — RxCUI 1486691

RxNorm drug concept · Semantic branded drug
RxCUI 1486691 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1486691
Official nameSapropterin dihydrochloride 100 MG Oral Tablet [Kuvan]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKuvan 100 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)970 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sapropterin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sapropterin gives your body more of a helper molecule called BH4 that the enzyme responsible for breaking down phenylalanine needs to work. If you have BH4-responsive PKU, this can...
  • What exactly does sapropterin do, and why do I still have to follow a special diet?
  • Your doctor will check your blood phenylalanine levels regularly after you start the medication. If the drug is working, your levels should start to drop within the first 24 hours,...
  • How will I know if sapropterin is actually working for me?
📖 Read our full Sapropterin guide →

🕸️ Concept Web — How Sapropterin dihydrochloride 100 MG Oral Tablet [... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sapropterin dihydrochloride 100 MG Oral Tablet [Kuvan] RxCUI 1486691

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sapropterin 753340
    • Sapropterin dihydrochloride 753341
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kuvan 751628
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sapropterin Oral Tablet 1102010
    • Sapropterin dihydrochloride Oral Tablet 2649279
    • Sapropterin Oral Product 1157609
    • Sapropterin Pill 1157610
    • Sapropterin dihydrochloride Oral Product 2662130
    • Sapropterin dihydrochloride Pill 2660270
    • Sapropterin Oral Tablet [Kuvan] 1486689
    • Sapropterin dihydrochloride Oral Tablet [Kuvan] 2657249
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sapropterin dihydrochloride 100 MG Oral Tablet SCD · 1486687
  • Sapropterin dihydrochloride 100 MG SCDC · 1486686
  • Sapropterin Oral Tablet SCDF · 1102010
  • Sapropterin dihydrochloride Oral Tablet SCDFP · 2649279
  • Sapropterin Oral Product SCDG · 1157609
  • Sapropterin Pill SCDG · 1157610
  • Sapropterin dihydrochloride Oral Product SCDGP · 2662130
  • Sapropterin dihydrochloride Pill SCDGP · 2660270

Brand-Name Concepts

  • Sapropterin dihydrochloride 100 MG [Kuvan] SBDC · 1486688
  • Sapropterin Oral Tablet [Kuvan] SBDF · 1486689
  • Sapropterin dihydrochloride Oral Tablet [Kuvan] SBDFP · 2657249
  • Kuvan Oral Product SBDG · 1174274
  • Kuvan Pill SBDG · 1486690
  • Kuvan BN · 751628

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1486691 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68135-0300-02 120 TABLET in 1 BOTTLE (68135-300-02) Kuvan BioMarin Pharmaceutical Inc. 2007-12-14
68135-0301-22 30 PACKET in 1 CARTON (68135-301-22) / 1 POWDER, FOR SOLUTI... Kuvan BioMarin Pharmaceutical Inc. 2014-02-21
68135-0482-11 30 PACKET in 1 CARTON (68135-482-11) / 1 POWDER, FOR SOLUTI... Kuvan BioMarin Pharmaceutical Inc. 2015-05-27
Observed labelers: BioMarin Pharmaceutical Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.